期刊文献+

老年2型糖尿病患者血浆同型半胱氨酸水平的变化 被引量:2

Changes of plasma homocysteine levels in the elderly with type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨老年2型糖尿病(T2DM)患者血浆同型半胱氨酸(Hcy)水平的变化。方法126例老年(年龄>65岁)T2DM患者为T2DM组,选择同期就诊的30例健康体检者为对照组,测定两组血糖、血脂和Hcy水平;采用彩色多普勒超声对T2DM患者下肢血管病变进行诊断。结果T2DM组Hcy为(9.6±2.5)μmol/L,明显高于对照组的(5.4±1.6)μmol/L(P<0.05);有血管病变(59例)的T2DM患者Hcy水平为(10.8±3.6)μmol/L,明显高于(67例)无血管病变患者的(8.6±2.5)μmol/L(P<0.05)。Spearman相关性分析显示,T2DM患者血浆Hcy水平与血管病变程度呈明显的正相关(r=6.43,P<0.05)。结论血浆Hcy水平与T2DM血管病变的发生明显相关,其机制可能与糖尿病性血管内皮损伤有关。 Objective To investigate the changes of plasma homocysteine(Hcy) levels in the elderly with type 2 diabetes mellitus(T2DM). Methods Blood glucose, blood lipids and Hcy were measured in 126 T2DM patients(group A), aged elder than 65 years, which were compared to those in 30 healthy people(group C). The vascular lesions in the lower extremities of T2DM cases were diagnosed by color Doppler ultrasound. Results Plasma Hcy level in group A was (9. 6_±2. 5) μnol/L, which was higher than (5.4±1.6) μmol/L in group C(P〈0. 05). Plasma Hcy level in T2DM cases with vascular lesions was (10. 8 ±3.6) μmol/L, which was higher than (8. 6±2.5) tlmol/L in those without vascular disease(P〈0. 05). Spearman correlation analysis showed that plasma Hcy level was positively correlated to the vascular lesions in T2DM patients (r=6. 43, P〈0. 05). Conclusion Plasma Hcy level is closely related to the occurrence of diabetic angiopathy in T2DM patients, which may be related to vascular endothelial injury.
作者 邱建刚
出处 《江苏医药》 CAS 北大核心 2013年第6期680-682,共3页 Jiangsu Medical Journal
关键词 2型糖尿病 同型半胱氨酸 糖尿病血管病变 Type 2 diabetes mellitus Homocysteine Diabetic angiopathy
  • 相关文献

参考文献7

  • 1Wild S, Roglie G, Green A, et al. A global prevalence of diabe- tes:estimates for the year 2000 and projections for 2030[J]. Diabetes Care, 2004,27(5) : 1047-1053.
  • 2杨瑞雪,沈捷,马向华.糖尿病微血管病变分子机制研究进展[J].医学综述,2010,16(20):3136-3138. 被引量:11
  • 3Sun Y, Chien KL, Hsu HC, et al. Use of serum homocysteine to predict stroke, coronary heart disease and death in ethnic Chinese. 12-year prospective cohort study[J]. Circ J, 2009,73 (8) : 1423-1430.
  • 4Washio T, Nomoto K, Watanabe I, et. al. Relationship between plasma homoeysteine levels and congestive heart failure in pa- tients with acute myocardial infarction. Homoeysteine and con- gestive heart failure[J]. Int Heart J, 2011,52 (4) : 224-228.
  • 5宋宛竹,李季.彩色多普勒超声诊断仪评价糖尿病下肢血管病变的价值[J].中国组织工程研究与临床康复,2007,11(44):8969-8971. 被引量:6
  • 6郭清华,陆菊明,秦海红,盛春燕,尹士男,潘长玉.2型糖尿病微血管病变患者血浆同型半胱氨酸的变化及其机制的探讨[J].中国糖尿病杂志,2002,10(1):32-36. 被引量:96
  • 7Katsuki A, Sumida Y, Urakawa H, et al. Increased visceral fat and serum levels of triglyceride are associated with insulin re- sistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance [J]. Diabetes Care, 2003,26 (8) : 2341-2344.

二级参考文献29

  • 1王玉珍,许樟荣.第五届国际血管外科暨第一届国际糖尿病血管疾病会议(糖尿病足部分)纪要[J].中华糖尿病杂志(1006-6187),2005,13(2):152-153. 被引量:184
  • 2张松菁,严孙杰,刘新秀,潘时中,杨立勇.糖代谢紊乱患者的血管内皮细胞功能变化[J].中华内分泌代谢杂志,2006,22(1):11-14. 被引量:35
  • 3Yamagishi S.Advanced glycation end products and receptor-oxidafive stress system in diabetic vascular complications[J].Ther Apher Dial,2009,13(6):534-539.
  • 4Chandra D,Ramana KV,Friedrich B,et al.Role of aldose reductase in TNF-alpha-induced apoptosis of vascular endothelial cells[J].Chem Biol Interact,2003(143/144):605-612.
  • 5Ramirez MA,Borja NL.Epalrestat:an aldose reductase inhibitor for the treatment of diabetic neuropathy[J].Pharmacotherapy,2008,28(5):646-655.
  • 6Wei W,Liu Q,Tan Y,et al.Oxidative stress,diabetes,and diabetic complications[J].Hemoglobin,2009,33(5):370-377.
  • 7Taniyama Y,Griendling KK.Reactive oxygen species in the vasculature:molecular and cellular mechanisms[J].Hypertension,2003,42(6):1075-1081.
  • 8Hara T,Ishida T,Cangara HM,et al.Endothelial cell-selective adhesion molecule regulates albuminuria in diabetic nephropathy[J].Microvasc Res,2009,77(3):348-355.
  • 9Atlas SA.The renin-angiotensin aldosterone system:pathophysiological role and pharmacologic inhibition[J].J Manag Care Pharm,2007,13(8 Suppl B):9-20.
  • 10Hen KH,Kang YS,Han SY,et al.Spironolactone ameliorates renal injury and connective tissue growth factor expression in type Ⅱ diabetic rats[J].Kidney hat,2006,70(1):111-120.

共引文献110

同被引文献13

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部